Back
Replimune Group, Inc. 10K Form
Sell
30
REPL
Replimune Group, Inc.
Last Price:
$7.75
Seasonality Move:
-8.3%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive REPL News And Ratings
See the #1 stock for the next 7 days that we like better than REPL
REPL Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-66.1M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.64 |
| Price / Book: | 3.04 |
Profitability
| EPS (TTM): | -3.58250 |
|---|---|
| Net Income (TTM): | $-314.9M |
| Gross Margin: | $-3.5M |
| Return on Equity: | -92.13% |
| Return on Assets: | -67.06% |
Replimune Group, Inc. Earnings Forecast
Key Replimune Group, Inc. Financial Ratios
-
Per Share Earnings over the last 9 years have been positive in 1 years.
Replimune Group, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | REPL |
| CUSIP: | 76029N |
| Website: | replimune.com |
Debt
| Debt-to-Equity Ratio: | 0.36 |
|---|---|
| Current Ratio: | 5.6 |
| Quick Ratio: | 5.37 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
REPL Technical Analysis vs Fundamental Analysis
Sell
30
Replimune Group, Inc. (REPL)
is a Sell
Is Replimune Group, Inc. a Buy or a Sell?
-
Replimune Group, Inc. stock is rated a SellThe current Replimune Group, Inc. [REPL] share price is $7.75. The Score for REPL is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.